Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study

American Heart Journal

Volumn 160, Issue 3, 2010, Pages 464-470

  Peacock, James M ^a   Ohira, Tetsuya ^b   Post, Wendy ^c,d   Sotoodehnia, Nona ^e   Rosamond, Wayne ^f   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONFOUNDING VARIABLE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK REDUCTION; SUDDEN DEATH; BLOOD; DEATH, SUDDEN, CARDIAC; MIDDLE AGED; RISK FACTOR;

ATHEROSCLEROSIS; DEATH, SUDDEN, CARDIAC; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 77956369663     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.012     Document Type: Article

References (38)

1. Zheng Z.J., Croft J.B., and Giles W.H. Sudden cardiac death in the United States, 1989 to 1998 Circulation 104 2001 2158 2163
2. Fox C.S., Evans J.C., and Larson M.G. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999-the Framingham Heart Study Circulation 110 2004 522 527
3. Gerber Y., Jacobsen S.J., and Frye R.L. Secular trends in deaths from cardiovascular diseases-a 25-year community study Circulation 113 2006 2285 2292
4. Albert C.M., Chae C.U., and Grodstein F. Prospective study of sudden cardiac death among women in the United States Circulation 107 2003 2096 2101
5. Assessment and oral management of micronutrient deficiency D.H. Alpers, R.E. Clouse, W.F. Stenson, Manual of nutritional therapeutics 2nd ed. 1988 Little, Brown and Company Boston 90 94
6. Jee S.H., Miller E.R. III, and Guallar E. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials Am J Hypertens 15 2002 691 696
7. Peacock J.M., Folsom A.R., and Arnett D.K. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 9 1999 159 165
8. Kao W.H., Folsom A.R., and Nieto F.J. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study Arch Intern Med 159 1999 2151 2159
9. He K., Liu K., and Daviglus M.L. Magnesium intake and incidence of metabolic syndrome among young adults Circulation 113 2006 1675 1682
10. Liao F., Folsom A.R., and Brancati F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 136 1998 480 490
11. Ma J., Folsom A.R., and Melnick S.L. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study J Clin Epidemiol 48 1995 927 940
12. Chakraborti S., Chakraborti T., and Mandal M. Protective role of magnesium in cardiovascular diseases: a review Mol Cell Biochem 238 2002 163 179
13. Eisenberg M.J. Magnesium deficiency and sudden death Am Heart J 124 1992 544 549
14. Gettes L.S. Electrolyte abnormalities underlying lethal and ventricular arrhythmias Circulation 85 1 Suppl 1992 I70 I76
15. Fletcher G.F., Sweeney M.E., and Fletcher B.J. Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade Am Heart J 121 1991 105 110
16. Rylander R., Megevand Y., and Lasserre B. Moderate alcohol consumption and urinary excretion of magnesium and calcium Scand J Clin Lab Invest 61 2001 401 405
17. The ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives Am J Epidemiol 129 1989 687 702
18. Eckfeldt J.H., Chambless L.E., and Shen Y.L. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study Arch Pathol Lab Med 118 1994 496 500
19. Baecke J.A., Burema J., and Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies Am J Clin Nutr 36 1982 936 942
20. Willett W.C., Sampson L., and Stampfer M.J. Reproducibility and validity of a semiquantitative food frequency questionnaire Am J Epidemiol 122 1985 51 65
21. Rautaharju P.M., MacInnis P.J., and Warren J.W. Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys Methods Inf Med 29 1990 362 374
22. Prineas R.J., Crow R.S., and Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings 1982 John Wright PSB Boston 203
23. Bazett H.C. An analysis of the time-relations of electrocardiograms Heart 7 1920 353 370
24. Hannan P.J., and Crow R.S. Concerning the units for the QT interval corrected by Bazett's formula Circulation 96 1997 3799
25. de Vreede-Swagemakers J.J., Gorgels A.P., and Weijenberg M.P. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease J Clin Epidemiol 52 1999 601 607
26. Jouven X., Desnos M., and Guerot C. Predicting sudden death in the population: the Paris Prospective Study I Circulation 99 1999 1978 1983
27. Altura B.M., and Altura B.T. Role of magnesium in the pathogenesis of hypertension: relationship to its actions on cardiac and vascular smooth muscle 1990 Raven Press New York, NY
28. Grobbee D.E., and Hoes A.W. Non-potassium-sparing diuretics and risk of sudden cardiac death J Hypertens 13 1995 1539 1545
29. Hoes A.W., Grobbee D.E., and Lubsen J. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients Ann Intern Med 123 1995 481 487
30. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic JAMA 288 2002 2981 2997
31. Wing L.M., Reid C.M., and Ryan P. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly N Engl J Med 348 2003 583 592
32. Abbott L.G., and Rude R.K. Clinical manifestations of magnesium deficiency Miner Electrolyte Metab 19 1993 314 322
33. Parikka H., Toivonen L., and Naukkarinen V. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction Eur Heart J 20 1999 111 120
34. Prielipp R.C., Butterworth J.F., and Roberts P.R. Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: a possible mechanism for its antiarrhythmic effects Anesth Analg 80 1995 1083 1087
35. Woods K., Fletcher S., and Roffe C. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet 339 1992 1553 1558
36. Woods K.L., and Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet 343 1994 816 819
37. ISIS-4 Collaborative Group ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
38. The Magnesium in Coronaries (MAGIC) Trial Investigators Early administration of magnesium in high-risk patients with STEMI had no effect on 30-day mortality. There was no indication for the routine administration of magnesium in patients with STEMI Lancet 360 2002 1189 1196